AAirway Shield — Pre-seed (estimated) · approximately €400K
Airway Shield closed its first round on Capital Cell, passing its €320K target in under 24 hours. The campaign finished at €400K, 125% of the goal. The company's investor page calls this Round I (about €400K, led by an unnamed Santander investor group), and other sources say €410K.
Lead not disclosed
RoundPre-seed (estimated)
Announced28 Aug 2021
CitySantander
SectorHealthtech & Bio · Medtech
Source
T
T
The company
Investors
No investors were disclosed for this round.